Zentiva as is a Slovakia-based company engaged in generic pharmaceuticals business sector. The Company develops, manufactures, and sells generic medicinal products, primarily used in primary care sector. Its portfolio includes preparations for various therapeutic areas, including cardiovascular system, womenâ€™s healthcare, respiratory system, antimicrobials, urological system, central nervous system, pain, and gastrointestinal system.

Employees

Sector

Pharmaceuticals

More about the company

End-of-day quote Bratislava S.E. 2026-08-20			5-day change	1st Jan Change
31.00 ^EUR	-.--%		-.--%	+3.33%

03-16	Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet	RE
02-23	Zentiva as responds to EU court decision on UWWTD	RE

Market Cap	243M 212M 200M 182M 340M 23.32B 342M 2.4B 925M 11.86B 913M 893M 38.15B	P/E 2017	7.27x	P/E 2018	177x
Enterprise Value	242M 211M 199M 181M 339M 23.25B 341M 2.39B 922M 11.82B 910M 890M 38.03B	EV / Sales 2017	3.97x	EV / Sales 2018	11.2x
Free-Float	4.05%	Yield 2017	13.8%	Yield 2018	-

03-16	Zentiva publishes 2025 sustainability report reinforcing commitment to people, partners and the planet	RE
02-23	Zentiva as responds to EU court decision on UWWTD	RE
25-09-11	Deals of the Day-Mergers and acquisitions	RE
25-09-11	Deals of the Day-Mergers and acquisitions	RE
25-09-11	Zentiva announces sale from Advent to GTCR	RE
25-09-11	Private equity firm Advent to sell drugmaker Zentiva to GTCR	RE
25-09-11	Deals of the Day-Mergers and acquisitions	RE
25-09-10	Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports	RE
25-09-10	Advent strikes $4.8 billion deal to sell Zentiva to GTCR, FT reports	RE
25-09-10	Advent strikes EUR4.1bn deal to sell generic drugmaker Zentiva to GTCR - FT	RE
25-08-20	India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports	RE
25-08-20	India's Aurobindo Pharma leads race to buy generic drugmaker Zentiva for $5.5 billion, Economic Times reports	RE
13-02-20	Wood Pharma Holding a.s. completed the acquisition of Hlohovec Production Plant from Zentiva A.S..	CI

6 months	+3.33%
Current year	+3.33%

Zentiva, Stock

Stocks

1SKF401E

SK1120004439

Pharmaceuticals

Valuation: Zentiva,

Chart: Zentiva,

Latest news: Zentiva,

Press Releases: Zentiva,

Quotes and Performance

Price Extremes

Managers and Directors: Zentiva,

Generic Pharmaceuticals

Financials

Company Profile

Current year	29	33
1 year	29	45
3 years	24	45
5 years	24	45
10 years	11	370

Manager	Title	Age	Since
Thomas Cornelis Koene CEO	Chief Executive Officer	-	2015-11-11
Hacho Agop Hatchikian PRN	Corporate Officer/Principal	-	2022-08-17

Director	Title	Age	Since
Mojmír Krutý BRD	Director/Board Member	-	2013-07-07
Martin Albert BRD	Director/Board Member	-	2018-10-17
Kenneth Lynard BRD	Director/Board Member	58	2020-11-14

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ZENTIVA,	-.--%	-.--%	-31.11%	+3.33%	57.6M
SUN PHARMACEUTICAL INDUSTRIES LTD.	-1.61%	-0.15%	+10.95%	+60.09%	45.94B
OTSUKA HOLDINGS CO., LTD.	-1.02%	-1.90%	+36.59%	+99.64%	37.22B
ZYDUS LIFESCIENCES LIMITED	+2.19%	+3.65%	+11.83%	+80.29%	12.06B
CIPLA LIMITED	+1.32%	+2.09%	-11.51%	+12.41%	11.74B
KRKA, D. D.	-0.95%	0.00%	+19.27%	+141.86%	9.03B
GEDEON RICHTER	+0.39%	+2.39%	+31.05%	+39.38%	7.36B
ONO PHARMACEUTICAL CO., LTD.	-0.06%	+2.97%	+39.67%	-18.37%	7.15B
GLENMARK PHARMACEUTICALS LIMITED	+1.30%	+1.17%	+17.37%	+187.41%	7.2B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+0.70%	+1.10%	-41.96%	+5.34%	5.03B
Average	+0.23%	+0.98%	+8.21%	+61.14%	14.28B
Weighted average by Cap.	-0.44%	+0.23%	+17.31%	+72.83%

	2017	2018
Net sales	143M 124M 117M 107M 200M 13.69B 201M 1.41B 543M 6.96B 536M 524M 22.4B	36.17M 31.54M 29.78M 27.05M 50.67M 3.47B 50.89M 357M 138M 1.76B 136M 133M 5.68B
Net income	77.98M 68M 64.2M 58.3M 109M 7.48B 110M 769M 297M 3.8B 293M 286M 12.24B	2.29M 2M 1.89M 1.71M 3.21M 220M 3.22M 22.59M 8.72M 112M 8.6M 8.41M 359M
Net Debt	-0.09 -0.08 -0.08 -0.07 -0.13 -8.83 -0.13 -0.91 -0.35 -4.49 -0.35 -0.34 -14.44	-0.77 -0.67 -0.64 -0.58 -1.08 -74.27 -1.09 -7.63 -2.95 -37.76 -2.91 -2.84 -121.5